| Dr Olivia Rose Tanasse, DC | |
|
344 Cleveland Ave Se Ste D, Tumwater, WA 98501-3342 | |
| (360) 357-5170 | |
| (360) 357-5173 |
| Full Name | Dr Olivia Rose Tanasse |
|---|---|
| Gender | Female |
| Speciality | Chiropractor |
| Location | 344 Cleveland Ave Se Ste D, Tumwater, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073239927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CH61355334 (Washington) | Primary |
| Provider Name | Tanasse Chiropractic, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689744534 PECOS PAC ID: 3971597733 Enrollment ID: O20040413001741 |
News Archive
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
In a new take on use of luminescent nanoparticles as cancer imaging probes, a team of investigators from several research institutes in Paris, France, has developed new metal-containing nanoparticles that emit light for several hours after they are initially excited.
Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.
XTL Biopharmaceuticals announced yesterday, March 18, 2012, it successfully completed a private placement of securities with foreign as well as Israeli institutional and private investors for a total of $2.4 million (NIS 9.1 million).
Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps prostate cancer cells metastasize (spread) to other parts of the body. This mechanism highlights new potential targets for cancer therapies and challenges the previous understanding of PLK1's role in cancer growth and progression.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Olivia Rose Tanasse, DC 344 Cleveland Ave Se Ste D, Tumwater, WA 98501-3342 Ph: (360) 357-5170 | Dr Olivia Rose Tanasse, DC 344 Cleveland Ave Se Ste D, Tumwater, WA 98501-3342 Ph: (360) 357-5170 |
News Archive
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
In a new take on use of luminescent nanoparticles as cancer imaging probes, a team of investigators from several research institutes in Paris, France, has developed new metal-containing nanoparticles that emit light for several hours after they are initially excited.
Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.
XTL Biopharmaceuticals announced yesterday, March 18, 2012, it successfully completed a private placement of securities with foreign as well as Israeli institutional and private investors for a total of $2.4 million (NIS 9.1 million).
Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps prostate cancer cells metastasize (spread) to other parts of the body. This mechanism highlights new potential targets for cancer therapies and challenges the previous understanding of PLK1's role in cancer growth and progression.
› Verified 9 days ago
Dr. Ronald Dale Wilcox, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 204 Pinehurst Dr Sw, Suite 103, Tumwater, WA 98501 Phone: 360-352-8112 Fax: 360-352-8113 | |
Clotilde Jeanne Schmidt, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 310 Cleveland Ave Se, Tumwater, WA 98501 Phone: 360-943-6015 Fax: 360-943-2807 | |
Dr. Ronnie Lee Douglas, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 204 Erie St Se, Tumwater, WA 98501 Phone: 360-943-2285 Fax: 360-943-3085 | |
Dr. Terry E. Swartling, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 121 Cleveland Ave Se, Tumwater, WA 98501 Phone: 360-754-8418 Fax: 360-754-0060 | |
Chris Juergens Dc Chiropractor Medicare: Medicare Enrolled Practice Location: 100 Ruby St Se Ste F, Tumwater, WA 98501 Phone: 360-943-4797 Fax: 360-709-0542 | |
Lowery Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 200 W St Se Ste A, Tumwater, WA 98501 Phone: 360-786-8600 |